Latest filing published 01 Jul 2021 for PRA Health Sciences, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Matthew P. Young across 2 companies, led by Jazz Pharmaceuticals plc and PRA Health Sciences, Inc. Between 5 May 2014 and 1 July 2021, the trades on record add up to 60 filings.
No open-market purchase appears, only 24 sales worth €3.0M. Other entries cover 32 share grants and 1 option exercise.
The record was last updated on 1 July 2021 with a transaction in PRA Health Sciences, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations